Sunday, December 4, 2022

Sale of Remdesivir, Favipiravir, other Covid drugs: SC asks for details of govt rules before taking up case

Want create site? Find Free WordPress Themes and plugins.

New Delhi: The Supreme Court today adjourned a plea seeking prosecution of pharmaceutical companies selling unlicensed drugs as Covid-19 vaccine, asking the counsel to study the government rules concerning the issue. 

A bench led by Chief Justice SA Bobde heard the plea seeking prohibition of use of uncertified and unlicensed drugs like Remdesivir and Favipiravir as Covid-19 medicine. The court will take up the matter after two weeks.

According to the plea by advocate ML Sharma, ten pharmaceutical companies have been selling medicines without any licence, claiming that they were Covid-19 vaccines and should be prosecuted. The plea alleged that these companies have used the media hype to sell their drugs and have tried to use the Covid-19 fear to exploit people. 

Read Also: SC orders fresh probe into mysterious death of NLU student- Read Judgment

The plea has also sought prohibition of use of unapproved and under trial drugs like Remdesivir and Favipiravir as Covid-19 medicines till they get certified. It states that these drugs can be allowed to be tested only during emergencies and under strict terms to report it to the regulator. 

– India Legal Bureau

Did you find apk for android? You can find new Free Android Games and apps.

News Update